Skip to main content
    O

    Option Care Health Inc (OPCH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $31.71
    +0.06 (+0.19%)

    Market Cap: $4.74B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Option Care Health Inc (OPCH) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Option Care Health (OPCH) is expected to report earnings on Jan 11, 2027. In the quarter ended Sep 30, 2026, Option Care Health reported EPS of $0.44, in line with the $0.44 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    60%(24/40)
    Avg Surprise
    +24.40%

    Upcoming Estimates

    Reports Jan 11, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.56
    Range$0.52 - $0.59
    14 analysts
    Revenue Consensus
    $1.53B
    Range$1.46B - $1.59B
    13 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.45
    Range$0.42 - $0.50
    8 analysts
    EPS Revisions
    3
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$0.44+1.0%
    60d ago$0.44+1.0%
    30d ago$0.44+0.8%
    7d ago$0.44+0.8%
    Current$0.45
    Revenue Consensus
    $1.45B
    Range$1.42B - $1.50B
    7 analysts

    Next Report

    OPCH has an expected report date of Jan 11, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 21.7% above the $0.46 reported for the quarter ended Dec 31, 2025.

    OPCH Earnings Call

    The latest OPCH earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, OPCH beat 24, missed 12 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $1.49B, up 3.5% from $1.44B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.44$0.44N/A0.00%In line-2.2%115 up, 3 downNov 4, 2026$1.49B
    Jun 30, 2026$0.41$0.37N/A+10.81%Beat0.0%110 up, 1 downJul 29, 2026$1.44B
    Mar 31, 2026$0.40$0.37$0.35 - $0.39+8.11%Beat0.0%100 up, 3 downApr 30, 2026$1.35B
    Dec 31, 2025$0.46$0.47$0.45 - $0.50-1.20%Miss+24.5%103 up, 0 downFeb 24, 2026$1.47B
    Sep 30, 2025$0.45$0.43$0.41 - $0.44+4.65%Beat+36.4%73 up, 2 downOct 30, 2025$1.44B
    Jun 30, 2025$0.41$0.40$0.38 - $0.41+2.50%Beat+32.3%61 up, 3 downJul 30, 2025$1.42B
    Mar 31, 2025$0.40$0.34$0.27 - $0.36+17.65%Beat+48.1%73 up, 0 downApr 29, 2025$1.33B
    Dec 31, 2024$0.37$0.36$0.32 - $0.44+2.01%Beat+15.5%51 up, 0 downFeb 26, 2025$1.35B
    Sep 30, 2024$0.33$0.32$0.28 - $0.36+3.13%Beat0.0%90 up, 0 downOct 30, 2024$1.28B
    Jun 30, 2024$0.31$0.28$0.25 - $0.31+10.71%Beat+3.3%90 up, 0 downJul 31, 2024$1.23B
    Mar 31, 2024$0.27$0.22$0.19 - $0.25+22.73%Beat+28.6%80 up, 1 downApr 23, 2024$1.15B
    Dec 31, 2023$0.32$0.29$0.26 - $0.31+10.34%Beat+33.3%80 up, 0 downFeb 22, 2024$1.12B
    Sep 30, 2023$0.33$0.29$0.24 - $0.31+13.79%Beat+57.1%80 up, 0 downOct 25, 2023$1.09B
    Jun 30, 2023$0.30$0.24$0.19 - $0.27+25.00%Beat+50.0%80 up, 0 downJul 27, 2023$1.07B
    Mar 31, 2023$0.21$0.18$0.15 - $0.20+16.67%Beat+16.7%80 up, 0 downMay 3, 2023$1.02B
    Dec 31, 2022$0.24$0.24$0.19 - $0.240.00%In line-41.5%60 up, 0 downFeb 23, 2023$1.03B
    Sep 30, 2022$0.21$0.24N/A-12.50%Miss-4.5%60 up, 0 downOct 27, 2022$1.02B
    Jun 30, 2022$0.20$0.22$0.17 - $0.26-9.09%Miss+5.3%60 up, 0 downJul 27, 2022$980.82M
    Mar 31, 2022$0.18$0.12$0.11 - $0.16+50.00%Beat+100.0%60 up, 0 downApr 28, 2022$915.78M
    Dec 31, 2021$0.41$0.24$0.20 - $0.29+70.83%Beat+310.0%60 up, 0 downFeb 23, 2022$927.19M
    Sep 30, 2021$0.22$0.22$0.14 - $0.220.00%In line+266.7%71 up, 0 downNov 4, 2021$891.94M
    Jun 30, 2021$0.19$0.10$0.06 - $0.11+90.00%Beat+1800.0%7N/AAug 3, 2021$860.27M
    Mar 31, 2021$0.09$0.04-$0.01 - $0.04+125.00%BeatN/A6N/AMay 6, 2021$759.24M
    Dec 31, 2020$0.10$0.07$0.03 - $0.09+42.86%BeatN/A6N/AMar 11, 2021$804.71M
    Sep 30, 2020$0.06-$0.01-$0.08 - -$0.01+700.00%BeatN/A5N/ANov 3, 2020$781.61M
    Jun 30, 2020$0.01-$0.14-$0.18 - -$0.04+107.14%BeatN/A5N/AAug 4, 2020$740.85M
    Mar 31, 2020-$0.06-$0.07-$0.12 - -$0.04+14.29%BeatN/A4N/AMay 7, 2020$705.44M
    Dec 31, 2019-$0.09-$0.06N/A-50.00%MissN/AN/AN/AMar 5, 2020$720.78M
    Sep 30, 2019-$0.07-$0.08N/A+12.50%BeatN/AN/AN/ANov 6, 2019$615.88M
    Jun 30, 2019-$0.52-$0.35N/A-48.57%MissN/AN/AN/AJul 30, 2019$497.27M
    Mar 31, 2019-$0.40-$0.49N/A+18.37%BeatN/AN/AN/AMay 2, 2019$476.49M
    Dec 31, 2018-$0.56-$0.56N/A0.00%In lineN/AN/AN/AMar 15, 2019$1.10B
    Sep 30, 2018-$0.36-$0.30N/A-20.00%MissN/AN/AN/ANov 6, 2018$493.93M
    Jun 30, 2018-$0.56-$0.46N/A-21.74%MissN/AN/AN/AAug 7, 2018$175.79M
    Mar 31, 2018-$0.48-$0.53N/A+9.43%BeatN/AN/AN/AMay 10, 2018$168.58M
    Dec 31, 2017-$0.08-$0.08N/A-3.23%MissN/AN/AN/AMar 8, 2018$1.19B
    Sep 30, 2017-$0.48-$0.38N/A-26.32%MissN/AN/AN/ANov 2, 2017$198.69M
    Jun 30, 2017-$0.60-$0.48N/A-25.00%MissN/AN/AN/AAug 8, 2017$218.11M
    Mar 31, 2017-$0.72-$0.58N/A-24.14%MissN/AN/AN/AMay 4, 2017$217.81M
    Dec 31, 2016-$0.92-$0.34N/A-170.59%MissN/AN/AN/AMar 3, 2017$240.12M
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $1.72, up 34.4% from the year before. It was -$2.20 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$1.72+34.4%
    Dec 31, 2024$1.28+10.3%
    Dec 31, 2023$1.16+39.8%
    Dec 31, 2022$0.83-8.8%
    Dec 31, 2021$0.91+727.3%
    Dec 31, 2020$0.11N/A
    Dec 31, 2019-$1.08N/A
    Dec 31, 2018-$1.96N/A
    Dec 31, 2017-$1.88N/A
    Dec 31, 2016-$2.20N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 5,700 words across 14 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q2Jun 30, 20265,73914
    2026Q1Mar 31, 20268,08315
    2025Q4Dec 31, 20258,29214
    2025Q3Sep 30, 20257,09312
    2025Q2Jun 30, 20255,94811
    2025Q1Mar 31, 20257,94812
    2024Q3Sep 30, 20247,60112
    2024Q2Jun 30, 20248,14811

    2026Q2 Earnings Call

    Opening remarks

    Bob Okunski Vice President, Investor Relations Good morning, and welcome to Option Care Health's Second Quarter 2026 Earnings Conference Call. With me today are John Charles Rademacher, President and Chief Executive Officer and Meenal Anil Sethna, Executive Vice President and Chief Financial Officer. Before we begin, a reminder that today's discussion will include certain forward-looking statements that reflect our current assumptions and these forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from our expectations. We assume no obligation to update any forward-looking statement except as required by law. We will also use non-GAAP financial measures when talking about the company's performance and financial condition. For more information on the specific risks and uncertainties as well as our non-GAAP measures, we encourage you to review the information in today's press release which is posted on the Investor Relations portion of our website as well as in our Form 10-Ks and 10-Qs filed with the SEC. Finally, for the question-and-answer portion of today's call, we ask that you limit questions to one question and one follow-up per participant. With that, I will turn the call over to John. John?

    John Charles Rademacher President and Chief Executive Officer Thanks, Bob. Good morning, everyone, and thank you for joining us. We are pleased to share updates on our second quarter 2026 today. Before I do this, I want to take a moment to say thank you to the Option Care Health team for their unwavering commitment to the patients and communities that we serve every day. I am grateful to our team members whose dedication to clinical excellence, patient outcomes, and service quality continues to differentiate Option Care Health in the marketplace. Their efforts continue to strengthen our foundation and have contributed to the positive momentum we are seeing across the business. As recognition of the great work our team does on a daily basis, we are incredibly proud to be ranked number 15 on TIME's World's Most Impactful Companies of 2026 list, which was presented by TIME and Statista earlier in the second quarter. At a high level, as the nation's largest independent provider of home and alternate site infusion therapy, our strategy is built on a national scale with local responsiveness. Our comprehensive network of home infusion pharmacies and infusion suites, URAC-accredited specialty pharmacy centers of excellence, along with the breadth and depth of our nursing resources, uniquely positions us in the marketplace. We combine consistent high-quality clinical care with local access leveraging our platform of infusion suites and clinics to drive clinical innovation, while meeting patients where they want to be.

    Frequently Asked Questions About OPCH

    When is Option Care Health's next earnings date?

    Option Care Health's next earnings report is expected for Jan 11, 2027.

    Did OPCH beat earnings estimates last quarter?

    Option Care Health reported EPS of $0.44 for the quarter ended Sep 30, 2026, in line with the $0.44 estimate.

    What EPS do analysts expect from OPCH next quarter?

    The consensus EPS estimate for Option Care Health for the quarter ending Dec 31, 2026 is $0.56 from 14 analysts, with estimates from $0.52 to $0.59.

    How often does OPCH beat earnings estimates?

    Option Care Health beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +5.57%.